This Article Full Text Full Text (PDF) All Versions of this Article: 41/2/347    most recent 01.HYP.0000050646.79785.7Cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dunn, S. A. Articles by Thomas, T. H. Search for Related Content PubMed PubMed Citation Articles by Dunn, S. A. Articles by Thomas, T. H. Related Collections Gene expression

(Hypertension. 2003;41:347.)
© 2003 American Heart Association, Inc.

Scientific Contributions

Altered Tropomyosin Expression in Essential Hypertension

Stuart A. Dunn; Mobin Mohteshamzadeh; Ann K. Daly; Trevor H. Thomas

From the Department of Medicine (S.A.D., M.M., T.H.T.) and the Department of Pharmacological Sciences (A.K.D.), Medical School, University of Newcastle-Upon-Tyne, Newcastle, England.

Correspondence to Dr Stuart Dunn, Department of Medicine, Medical School, University of Newcastle-Upon-Tyne, Newcastle-Upon-Tyne, NE2 4HH, UK. E-mail s.a.dunn{at}ncl.ac.uk

Abnormal erythrocyte sodium-lithium countertransport is common in a subgroup of patients with essential hypertension and a strong family history of hypertension and cardiovascular disease. We have previously shown that the abnormality in sodium-lithium countertransport is associated with tropomyosin, a cytoskeletal protein required to stabilize actin filament formation. Leukocyte trafficking events, which depend on cytoskeletal reorganization, are also altered in patients with essential hypertension with abnormal sodium-lithium countertransport. The aim of this study was to determine whether there is an abnormality in isoforms of tropomyosin that are common to erythrocytes and leukocytes. Analysis of reticulocyte RNA by reverse transcription (RT) and polymerase chain reaction (PCR) showed expression of TPMN and TPM5b isoforms of tropomyosin. No other isoforms were expressed. These isoforms were also detected in RNA from leukocytes. In patients with essential hypertension with abnormal erythrocyte sodium-lithium countertransport compared with normal control subjects, there was a higher TPMN/TPM5b ratio of protein in erythrocytes (median 3.8 [range 1.8 to 6.6] versus 2.9 [1.9 to 4.0], P<0.001) and of RNA in leukocytes (3.7 [1.7 to 8.2] versus 2.6 [1.2 to 4.3], P<0.01). Furthermore, the protein ratio of TPMN/TPM5b in erythrocytes showed significant correlation with the V_max/K_m ratio of sodium-lithium countertransport across the patient groups (r=-0.42; P<0.01). Therefore, altered tropomyosin expression may be the underlying abnormality associated with blood cell membrane changes in essential hypertension and implicates the cytoskeleton in the pathogenesis of the disease in a major subgroup of patients.

Key Words: hypertension, essential • erythrocytes • sodium-lithium countertransport • leukocytes

This article has been cited by other articles:

				K. Nazeer, M. G. Janech, J. J.-C. Lin, K. J. Ryan, J. M. Arthur, and M. N. Budisavljevic Changes in protein profiles during course of experimental glomerulonephritis Am J Physiol Renal Physiol, January 1, 2009; 296(1): F186 - F193. [Abstract] [Full Text] [PDF]

				P. Gunning, G. O'neill, and E. Hardeman Tropomyosin-Based Regulation of the Actin Cytoskeleton in Time and Space Physiol Rev, January 1, 2008; 88(1): 1 - 35. [Abstract] [Full Text] [PDF]

				N. H. Lee, B. J. Haas, N. E. Letwin, B. C. Frank, T. V. Luu, Q. Sun, C. D. House, S. Yerga-Woolwine, P. Farms, E. Manickavasagam, et al. Cross-Talk of Expression Quantitative Trait Loci Within 2 Interacting Blood Pressure Quantitative Trait Loci Hypertension, December 1, 2007; 50(6): 1126 - 1133. [Abstract] [Full Text] [PDF]

				G. Schevzov, B. Vrhovski, N. S. Bryce, S. Elmir, M. R. Qiu, G. M. O'Neill, N. Yang, N. M. Verrills, M. Kavallaris, and P. W. Gunning Tissue-specific Tropomyosin Isoform Composition J. Histochem. Cytochem., May 1, 2005; 53(5): 557 - 570. [Abstract] [Full Text] [PDF]